D-1142-2023 Class III

Recalled by Lundbeck LLC — Deerfield, IL

FDA drug recall D-1142-2023 was initiated by Lundbeck LLC on Aug 17, 2023 and is designated Class III. Reason for recall: Cross contamination with other products Affected quantity: 10,543 cartons.

Recall details

Product Type
Drugs
Report Date
Sep 6, 2023
Initiation Date
Aug 17, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10,543 cartons

Product description

Sabril (vigabatrin) for Oral Solution, 500 mg, 50 Packets, Rx only, Manufactured by: Patheon, Cincinnati, OH 45237, NDC 67386-211-65

Reason for recall

Cross contamination with other products

Distribution pattern

Nationwide within the U.S.

Code information

Lot#: 3207333A, 3207334A, Exp 03/2027; 3214707A, 3214709A, 3214710A, Exp 02/2028 .

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1142-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1142-2023. Report a data issue: hello@regdatalab.com.